SYNERGIE GENE+ OUTCOMES

LIVE

Serial Number

98055817

Owner

Synergie Medication Collective, LLC

Attorney

Patricia I. Reding

First Use Date

Dec 15, 2023

Filing Date

Jun 23, 2023

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

SYNERGIE GENE+ OUTCOMES Trademark

Serial Number: 98055817 • Registration: 7645616

SYNERGIE GENE+ OUTCOMES is a trademark filed by Synergie Medication Collective, LLC on June 23, 2023. The trademark is classified under Class 35 (Advertising & Business). The application is currently registered and active.

Trademark Classes

Class 35 - Advertising & Business

Advertising; business management; business administration; office functions

Owner Contact Info

Synergie Medication Collective, LLC (5 trademarks)

1209 Orange Street
Wilmington, DE 19801

Entity Type: 16

Legal Representation

Attorney of Record

Patricia I. Reding

942 trademarks filed View all →

Correspondence Address

Patricia I. Reding FAEGRE DRINKER BIDDLE & REATH LLP

90 S. Seventh Street, Suite 2200

Minneapolis, MN 55402

United States

Trademark Details

Filing Date

June 23, 2023

Registration Date

January 7, 2025

First Use Anywhere

December 15, 2023

First Use in Commerce

December 15, 2023

Published for Opposition

January 30, 2024

Goods & Services

Administering discount group purchasing programs, namely, facilitating and negotiating gene therapy outcomes-based contracts with pharmaceutical manufacturers that require longitudinal patient tracking to assess therapy efficacy and durability, and value-based warranty payments to a risk pool to enable benefit plan participating health care payers to obtain discounts on the purchase of their goods or service

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jan 7, 2025 NRCC

REGISTERED-PRINCIPAL REGISTER

Jan 7, 2025 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Dec 16, 2024 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Dec 16, 2024 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Nov 16, 2024 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Nov 16, 2024 AITU

USE AMENDMENT FILED

Sep 16, 2024 IUAF

TEAS STATEMENT OF USE RECEIVED

Sep 16, 2024 EISU

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Mar 26, 2024 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 30, 2024 NPUB

PUBLISHED FOR OPPOSITION

Jan 30, 2024 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 10, 2024 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 22, 2023 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Dec 1, 2023 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 30, 2023 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 30, 2023 TROA

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Nov 29, 2023 EWAF

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Nov 29, 2023 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Nov 29, 2023 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Nov 29, 2023 REAP

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Nov 29, 2023 CHAN

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Nov 29, 2023 COAR

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Sep 26, 2023 GNRN

NON-FINAL ACTION E-MAILED

Sep 26, 2023 GNRT

NON-FINAL ACTION WRITTEN

Sep 26, 2023 CNRT

ASSIGNED TO EXAMINER

Sep 14, 2023 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 25, 2023 NWOS

NEW APPLICATION ENTERED

Jun 27, 2023 NWAP

Related Trademarks

More from this Owner

SYNERGIE CELL & GENE+ PATIENT NAVIGATION

SYNERGIE GENE+ RISK PROTECTION

More in Same Class